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The most common cause of surgical failure at 6
to 18 months after angioplasty and bypass graft
remains restenosis.1-3 The bulk of the mature intimal
hyperplastic lesion consists of extracellular matrix
that is secreted by dedifferentiated smooth muscle
cells (SMCs).4,5 Type I collagen is the major compo-
nent of the mature intimal hyperplastic lesion.
However, the extracellular matrix composition of the
early intimal hyperplastic lesion is different from that
of the mature lesion. Hyaluronanic acid, a gly-
cosaminoglycan, appears in the extracellular matrix
immediately after arterial injury and is present for
roughly the first 2 weeks after injury.6 Hyaluronanic
acid is a loosely interconnected molecule that has
been shown to potentiate migration of SMCs
through the extracellular matrix.7,8 In addition,
hyaluronanic acid has been shown to potentiate SMC
proliferation and is important in blood-vessel wall
development.7 Hyaluronanic acid stimulates SMC
migration through at least two different receptors:
CD44 and the receptor for hyaluronic acid–mediat-
ed motility (RHAMM).8,9 The RHAMM has been
shown to be required for SMC migration, and anti-
bodies to RHAMM have been shown to inhibit
migration.8 Moreover, hyaluronanic acid has been
shown to increase RHAMM expression.
The temporal expressions of the various matrix
proteins may be important in the pathobiology of
the restenotic response. Hyaluronanic acid, present
early in this process, could potentiate SMC prolifer-
ation and migration. SMCs then produce increasing
amounts of type I collagen, which may result in cica-
trix formation in the vascular wall and subsequent
restenosis.
Recent studies have shown that endothelial cell
(EC) seeding of angioplasty surfaces can favorably
affect arterial wall remodeling.10,11 The mechanism
by which ECs inhibit the development of intimal
hyperplasia and alter the SMC response to injury is
unknown. Our laboratory has shown recently that
ECs inhibit SMC type I collagen gene expression
and protein production.12 The purpose of the pre-
sent investigation was to examine the effect of ECs
on SMC hyaluronanic acid secretion. The hypothe-
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sis tested in this investigation was that ECs inhibit
SMC hyaluronanic acid synthesis and down-regulate
RHAMM expression. To test this hypothesis, we
used a coculture model in which ECs and SMCs
were cocultured on opposite sides of a semiperme-
able membrane.
METHODS
Cell culture. Bovine thoracic aortic ECs and
bovine thoracic SMCs were isolated and cultured in
Delbecco’s Modified Eagle’s Medium (Gibco BRL,
Grand Island, N.Y.) and in 10% calf serum (Gibco
BRL), with supplementation of L-glutamine-peni-
cillin-streptomycin solution (Sigma, St. Louis, Mo.).
ECs were identified with a monoclonal mouse anti-
body to human Willebrand factor (Dako-VWF,
F8/86, Dako, Carpinteria, Calif.), and SMCs were
identified with an a -smooth muscle actin antibody
(Sigma A 2547, Sigma). ECs and SMCs were grown
from primary passages and used for experimentation
at passages 4 to 12. Multiple primary cultures from
different thoracic aortas were used to ensure vari-
ability of cell lines and eliminate any unique response
to a single cell line.
Coculture model. This model has been
described extensively in previous publications.13-15
For each component of this study, SMC cultures
were established by plating cells on a 13-m m–thick
polyethylene terephthalate membrane with 0.4-m m
pores configured at a density of 1.6 million
pores/cm2 (Cyclopore membrane, Falcon cell cul-
ture insert, Becton Dickinson, Franklin Lakes, N.J.).
EC/SMC bilayer cocultures were established by
plating ECs on the outer side of the membrane and
allowing them to grow to confluence for 2 to 3 days.
Once confluent, as determined by means of phase-
contrast microscopy, SMCs were plated on the
opposite side of the membrane in 2.5% calf serum.
This serum was chosen because studies have shown
that 2.5% calf serum places the subconfluent SMCs
in a submaximal state of proliferation. This model
allows for diffusion of soluble factors across the
membrane and allows the SMCs and ECs to be
examined separately.
Hyaluronanic acid radioimmunoassay. Hya-
luronanic acid present in the conditioned media was
measured by means of a hyaluronanic acid radioim-
munoassay kit (HA Test 50, Pharmacia Biotech,
Kalamazoo, Mich.) with a 125I-labeled hyaluronic
acid–binding region (HABR) of aggrecan. In brief,
full-strength conditioned media was collected and
centrifuged to remove cellular debris. We mixed 100
m L of conditioned media with 200 m L of 125I-
labeled HABR and incubated the mixture for 60
minutes at 4° C. We then added 100 m L of hyaluro-
nanic acid–sepharose to absorb unbound 125I-
labeled HABR, and the mixtures then were incubat-
ed for 45 minutes at 4° C. Washing solution was
added, and each mixture was centrifuged for 10
minutes at 1500· g. The supernatants were discard-
ed, and the radioactivity that remained in the pellet
was determined in a gamma counter. The amount of
hyaluronanic acid present in the conditioned media
was calculated from a curve generated from hyaluro-
nanic acid standards. To account for differences in
cell number that occur in the different culture con-
ditions, SMCs from each group were treated with
trysin and counted on a Coulter counter (Coulter
Electronics Ltd., Hialeah, Fla.). Hyaluronanic acid
levels were calculated as micrograms per milliliter
per 106 SMCs.
Cell-associated hyaluronanic acid assay. Cell-
associated hyaluronanic acid was measured as
described by Azumi et al. with slight variation.16 In
brief, conditioned media underwent aspiration, and
cells then were washed once with cold phosphate-
buffered saline solution (PBS). Cells were fixed with
4% paraformaldehyde for 1 hour. ECs were removed
from the underside of the coculture with a cell
scraper. An additional wash with cold PBS was per-
formed to remove residual ECs and was followed by
incubation of SMCs for 5 minutes in 10% H2O2 to
inactivate endogenous peroxidases. This procedure
was followed by two washes in distilled H2O. SMCs
were washed once in calcium-free and magnesium-
free PBS. Cells then were incubated in biotynilated
glycosaminoglycan binding fragments (b-PB, gift
from Dr. C. B. Underhill, Georgetown University,
Washington, D.C.) that were dissolved in 10% calf
serum and 90% PBS at a concentration of 8 m g/ml.
After this incubation the cells were washed five times
in PBS for 1 minute. Sections were incubated for 15
minutes with a 1:500 dilution of streptavidin cou-
pled to horseradish peroxidase (KPL, Gaithersburg,
Md.) follwed by five repeated 1-minute washes of
PBS. The substrate 3-amino-9-ethylcarbazole
(Sigma) was then used to stain the sections with a
30-minute incubation.
The SMCs were counterstained with Mayer’s
hematoxylin at a 1:100 dilution in H2O for 30 sec-
onds. Sections were washed again in PBS and
mounted on glass slides in 50% glycerol. Photo-
graphs were taken with a Kodak Elite II camera,
with ASA 100 film (Eastman Kodak Co., N.J.). Cell-
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associated hyaluronanic acid then was quantitated
with the point hit method. Photomicrographs of
SMCs that were selected from similar areas in each
cell culture insert were placed onto a grid, and the
quantity of hyaluronanic acid was calculated as the
percentage of points that rested on stained areas of
the photomicrograph. This procedure was per-
formed in a blinded manner by two independent
observers, and the results were averaged.
Immunoblot analysis for RHAMM. Immu-
noblots were performed with lysates of SMCs after
48 hours in culture. Lysates were prepared with a
triple-lysis buffer that contained 25 mmol/L Tris,
0.1% sodium dodecylsulfate (SDS) · phenylmethyl-
sulfonyl fluoride, leupeptin, and aprotinin in PBS.
Sample buffer that contained Tris, 2 mmol/L ethyl-
eneglycol-bis-( b -aminoethylether)-N-tetraacetic
acid, 20% glycerol, 10% B-mercaptoethanol, 4% SDS,
and 0.001% bromophenol blue then was added, and
the mixture was boiled for 8 minutes and then
quenched on ice and stored at –20° C. Protein was
measured with the bicinchoninic acid kit according
to the manufacturer’s directions (H. Pierce,
Rockford, Ill.). We resolved 30 m g of protein per lane
on 10% SDS-polyacrylamide gel electrophoresis and
transferred this solution to nitrocellulose membranes
(Optitran, Schleicher & Schuell, Keene, N.H.) at
0.06 volts overnight at 4° C. Membranes were
blocked with 5% nonfat powdered milk (Carnation)
in Tween 20 and TBS (T-TBS; TBS, 20 mmol/L Tris,
130 mmol/L NaCl, pH 7.6) for 1 hour at room tem-
perature. Primary monoclonal antibody was used at a
1:500 dilution in T-TBS for 24 hours at 4° C on a
shaker. Blots then were washed three times in T-TBS
and incubated with horseradish peroxidase–conjugat-
ed rabbit antimouse IgG (1:5000 in T-TBS) for 1
hour. After T-TBS washing once, the blot was visual-
ized by enhanced chemiluminescence detection tech-
nique (Amersham International, Buckinghamshire,
England) according to the manufacturer’s instruc-
tions. The density of the autoradiographic signals
were quantitated as average intensity by area with an
image scanner and commercial software (NIH Image,
NIH, Bethesda, Md.). The primary RHAMM was a
gift from Dr. Eva A. Turley (Manitoba Institute of
Cell Biology, Manitoba, Canada).
Statistical analysis. All experiments were per-
formed at least in triplicate (n = 6 wells per group
/experiment), and data were pooled. Data are pre-
sented as the mean ± standard error of the mean.
Significant differences between groups were tested
as appropriate by analysis of variance and post hoc
Tukey test with a Macintosh computer and com-
mercial software (Systat Inc., Evanston, Ill.). A value
of p less than 0.05 was considered significant.
RESULTS
Effect of ECs on SMC hyaluronanic acid lev-
els in conditioned media. As shown in Fig. 1, the
SMCs that were cultured alone (425 ± 30
m g/ml/106 cells) had increased levels of hyaluro-
nanic acid in the conditioned media at all time
points studied when compared with the SMCs that
were cocultured opposite ECs (212 ± 30
m g/ml/106 cells). However, only at 48 hours was
this difference significant (p < 0.01).
Effect of ECs on SMC-associated hyaluronan-
ic acid levels. As shown in Fig. 2, ECs inhibited
SMC hyaluronanic acid production when compared
with SMCs cultured alone. Quantification of the cell-
associated hyaluronanic acid by point hit method
confirmed a significant decrease in hyaluronanic acid
production at all time points studied (Fig. 3).
Effect of ECs on SMC RHAMM expression.
Hyaluronanic acid has been shown to increase
RHAMM expressionin SMCs. A representative
immunoblot is shown in Fig. 4, A. Overall, SMCs
cocultured with ECs had a 50% ± 17% reduction in
RHAMM expression when compared with SMCs
cultured alone (n = 3; Fig. 4, B).
DISCUSSION
Studies recently have suggested that EC seeding
of injured arterial surfaces and prosthetic bypass
grafts can limit the degree of intimal hyperplasia
that subsequently occurs.10,17,18 The mechanism
for this limiting is unknown. Our laboratory has
used an in vitro bilayer coculture model to begin to
define these mechanisms. We have shown previous-
ly that ECs inhibit SMC type I collagen protein
production and gene expression.12 This inhibition is
important because 80% of the mature intimal hyper-
plastic lesion consists of extracellular matrix, which
is mostly type I collagen. In the present study, we
have shown that ECs inhibit SMC hyaluronanic
acid production.
Hyaluronanic acid, a glycosaminoglycan that
consists of repeating glucuronic acid/N-acetylglu-
cosamine disaccharides, is present in developing tis-
sues and in healing wounds. Hyaluronanic acid is
abundant in embryonic vascular tissue, but its
expression is much less in the mature arterial wall.7
Riessen et al.6 have shown that hyaluronanic acid is
increased in human coronary artery restenotic
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lesions when compared with primary atherosclerot-
ic lesions. In addition, these investigators have
shown that hyaluronanic acid is increased soon
after balloon injury in a rat carotid artery. An inter-
esting note in this animal model of carotid injury is
that reendothelialization after balloon injury typi-
cally occurs only to a limited extent in the proximal
and distal portions of the arterial surface.19 Most of
the injured surface does not undergo reendothe-
lialization. One possible explanation for the early
increase in hyaluronanic acid that was observed
after balloon injury may be the incomplete reen-
dothelialization of the arterial surface with subse-
quent loss of the EC-inhibitory effect on SMC
hyaluronanic acid production. In addition,
hyaluronanic acid has been identified in the diffuse
thickened intima overlying atherosclerotic lesions
but is absent in the lipid core.20
Hyaluronanic acid has been shown to potentiate
SMC migration through matrix and to stimulate
cell proliferation.7,8 Hyaluronanic acid stimulation
of cell migration is mediated through activation of
the CD44 receptor and RHAMM.9 RHAMM has
been shown to be required for SMC migration to
occur after arterial injury. Activation of RHAMM
results in disassembly of adhesion plaques, and anti-
bodies to RHAMM have been shown to inhibit
SMC migration.8
In the present study, we have shown that ECs
inhibit SMC production of hyaluronanic acid.
Similarly, we have shown that ECs inhibit SMC
expression of RHAMM. The mechanism of EC
inhibition of hyaluronanic acid expression is
unclear. This effect likely is mediated by an EC-syn-
thesized diffusable molecule because no significant
EC-SMC cell contact occurs in this coculture
model during the time frame studied. We have
shown previously that ECs inhibit transforming
growth factor- b 1 (TGF- b 1) activation in bilayer
coculture with SMCs.13,21 TGF- b 1 has been shown
to increase SMC hyaluronanic acid production and
to increase RHAMM RNA message levels.22-24
Thus, one possible mechanism by which ECs may
inhibit SMC hyaluronanic acid synthesis could be
through the inhibition of TGF- b 1 activity in cocul-
tured SMCs. However, ECs secrete numerous
other factors and soluble matrix proteins that could
cross the semipermeable membrane and inhibit
SMC hyaluronanic acid synthesis. The inhibition of
SMC hyaluronanic acid synthesis by ECs was more
Fig. 1. Hyaluronanic acid level in conditioned media of SMCs cultured alone (dashed line)
was greater at all time points studied as compared with SMCs cocultured with ECs (solid line).
However, only at 48 hours was this time point significant (*p < 0.05).
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pronounced in the SMC matrix than in the condi-
tioned media. The reason for this difference is
unclear. The difference could be caused by addi-
tional alterations in the SMC matrix that are
induced by ECs and that result in decreased
hyaluronanic acid binding to the SMC matrix.
Hyaluronanic acid stimulates RHAMM expres-
sion in SMCs, and so an additional mechanism by
which ECs may down-regulate SMC RHAMM
expression may be a consequence of the decrease in
SMC hyaluronanic acid levels present in coculture.
In summary, we have shown with a bilayer cocul-
ture model that ECs inhibit SMC hyaluronanic acid
secretion and RHAMM expression, which appears to
be mediated by an EC-synthesized diffusable mole-
cule. This finding may be important in EC regulation
of SMC function, such as SMC response to injury,
and in the control of blood-vessel wall development.
Fig. 2. Histochemical stain of SMCs for hyaluronanic acid. A, SMCs cultured alone at 8
hours; B, cocultured SMCs at 8 hours; C, SMCs cultured alone at 48 hours; D, cocultured
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Fig. 3. Hyaluronanic acid levels in extracellular matrix as determined by point hit method.
Dashed line shows SMCs cultured alone; solid line shows cocultured SMCs (*p < 0.05).
Fig. 4. A, Representative immunoblot for RHAMM. B, Corresponding densitometry (n = 3).
Cocultured SMCs had a 50% ± 17% reduction in RHAMM as compared with SMCs cultured
alone (p = 0.08).
A
B
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